doi: 10.1016/j.jpeds.2003.10.055.
Bilateral sensorineural deafness in adenosine deaminase-deficient severe combined immunodeficiency
Affiliations
- PMID: 14760277
- DOI: 10.1016/j.jpeds.2003.10.055
Item in Clipboard
Bilateral sensorineural deafness in adenosine deaminase-deficient severe combined immunodeficiency
J Pediatr.
2004 Feb.
Abstract
Adenosine deaminase deficiency presents with severe combined immunodeficiency and is treatable by bone marrow transplantation. With improved survival, the nonimmunologic manifestations of this condition are becoming apparent. We report a high incidence of bilateral sensorineural deafness in transplanted patients, which highlights the systemic nature of the disease.
Similar articles
-
Cognitive and behavioral abnormalities in adenosine deaminase deficient severe combined immunodeficiency.J Pediatr. 2001 Jul;139(1):44-50. doi: 10.1067/mpd.2001.115023. J Pediatr. 2001. PMID: 11445793
-
A case of adenosine deaminase-negative severe combined immunodeficiency with neurological abnormalities.Turk J Pediatr. 1995 Oct-Dec;37(4):383-9. Turk J Pediatr. 1995. PMID: 8560606
-
Cost analysis of treatments for severe combined immunodeficiency patients caused by adenosine deaminase deficiency: comparison of gene therapy and bone marrow transplantation.Hokkaido Igaku Zasshi. 1998 Mar;73(2):137-45. Hokkaido Igaku Zasshi. 1998. PMID: 9612707
-
[Adenosine deaminase deficiency].Ryoikibetsu Shokogun Shirizu. 2001;(33):150-1. Ryoikibetsu Shokogun Shirizu. 2001. PMID: 11462375 Review. Japanese. No abstract available.
-
[Adenosine deaminase deficiency].Ryoikibetsu Shokogun Shirizu. 2000;(32):32-4. Ryoikibetsu Shokogun Shirizu. 2000. PMID: 11212730 Review. Japanese. No abstract available.
Cited by
-
Comparison of elapegademase and pegademase in ADA-deficient patients and mice.Clin Exp Immunol. 2020 May;200(2):176-184. doi: 10.1111/cei.13420. Epub 2020 Feb 9. Clin Exp Immunol. 2020. PMID: 31989577 Free PMC article.
-
Delayed-onset adenosine deaminase deficiency with a novel synonymous mutation and a case series from China.World J Pediatr. 2023 Jul;19(7):687-700. doi: 10.1007/s12519-023-00729-3. Epub 2023 May 8. World J Pediatr. 2023. PMID: 37154862
-
Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.Biol Blood Marrow Transplant. 2017 Mar;23(3):379-387. doi: 10.1016/j.bbmt.2016.12.619. Epub 2017 Jan 6. Biol Blood Marrow Transplant. 2017. PMID: 28068510 Free PMC article. Review.
-
Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.Biol Blood Marrow Transplant. 2017 Aug;23(8):1229-1240. doi: 10.1016/j.bbmt.2017.04.026. Epub 2017 May 4. Biol Blood Marrow Transplant. 2017. PMID: 28479164 Free PMC article. Review.
-
Strimvelis® for Treating Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency: An Evidence Review Group Perspective of a NICE Highly Specialised Technology Evaluation.Pharmacoecon Open. 2019 Jun;3(2):151-161. doi: 10.1007/s41669-018-0102-3. Pharmacoecon Open. 2019. PMID: 30334168 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
